Back to search

Democritus University of Thrace (DUTH)

Μεταγραφικοί παράγοντες ιντερφερονών σε μοντέλα βλάβης του δικτύου δράσης των ιντερφερονών: ο ρόλος των interferon regulatory factor 1, 2 (IRF1, IRF2) στη χρόνια ιογενή ηπατίτιδα

Abstract

dc:description

Backgraund: Recent studies, involving animals and patients affected by chronic viral hepatitis (HBV and HCV), have shown that cellular antiviral responses are mediated partly by expression of interferon-stimulated genes. Interferon regulatory factor-1 (IRF-1) is a trenscriptional activator of genes critical for cell growth, immune responses and apoptosis and acts as a tumor suppressor gene, whereas IRF-2 acts as a transcriptional repressor of IRF-2. The aim of this study was to investigate intra-hepatic expression of both IRF-1 and IRF-2 in patients affected by chronic HBVand HCV infection (untreated and treated with IFNa, with or without cirrhosis) in comparison with that observed in normal individuals. The expression of both IRF-1 and IRF-2 was perfomed also in PBMCs of patients and normals. Materials and methods: Liver biopsy speciments from 25 patients with chronic hepatitis B (CHB), 16 patients with chronic hepatitis C (CHC) and 18 patients with cirrhosis (12 HBV and 6 HCV) were studeid. The control group included 8 patients with normal histological appearance of the liver. Also were studied PBMCs from patients and normal individuals. Semiquantitative analysis of full length IRF-1 and IRF-2 mRNA expression was perfomed using the Quantum RNA classic II 18S Kit. This is a semi-quantitative method that uses 18S rRNA as internal control. Results: Low intra-hepatic IRF-1 mRNA expression was observed in patients with both CHB and CHC as compared to normal individuals, whereas cirrhotic patients had nearly undetectable levels of IRF-1 mRNA expression. In contrast, IRF-2 mRNA intra-hepatic expression was nearly equal in both patients and normal controls. Significantly induction of IRF-1 mRNA intra-hepatic expression was observed after treatment with interferon alfa in 5 patients with CHB and 4 cirrhotic patients. The ratio of IRF-1/IRF-2 mRNA expression that was low before the treatment with IFNa was increased after the treatment. No significant differnces were observed inexpression both IRF-1 and IRF-2 in PBMCs of patients and that of normal controls. Conclusions: Low levels of IRF-1 mRNA intra-hepatic expression may be contributed to impaired immune responses and persistent infection in patients with chronic viral hepatitis. Futhermore, absence of IRF-1 mRNA intra-hepatic expression in conjunctionwith high levels of IRF-2 mRNA expression and as result of this the low ratio of IRF-1/IRF-2 mRNA expression in cirrhotic patients represents a mechanism of tumor suppressor inactivation which may be increase the risk of hepatocellular carcinoma (HCC). The clinical studies represent that fibrosis and even frank cirrhosis have appeared to regress after treatment of patients with chronic virl hepatitis with interferon alfa. May be the results of our study is one of the mechanisms that involved in this action of interferon a.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2007

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Spathari, Nikol
  • Σπαθάρη, Νικόλ

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/21122

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Spathari, Nikol; Σπαθάρη, Νικόλ. Μεταγραφικοί παράγοντες ιντερφερονών σε μοντέλα βλάβης του δικτύου δράσης των ιντερφερονών: ο ρόλος των interferon regulatory factor 1, 2 (IRF1, IRF2) στη χρόνια ιογενή ηπατίτιδα. Democritus University of Thrace (DUTH), 2007. http://hdl.handle.net/10442/hedi/21122